PABIR3
gene geneOn this page
Also known as RP3-473B4.1
Summary
PABIR3 (PABIR family member 3, HGNC:25202) is a protein-coding gene on chromosome Xq26.3, encoding PABIR family member 1 (Q6P4D5).
Predicted to enable protein serine/threonine phosphatase inhibitor activity.
Source: NCBI Gene 159091 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 71 total
- MANE Select transcript:
NM_001388447
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25202 |
| Approved symbol | PABIR3 |
| Name | PABIR family member 3 |
| Location | Xq26.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RP3-473B4.1 |
| Ensembl gene | ENSG00000156500 |
| Ensembl biotype | protein_coding |
| Entrez | 159091 |
Gene structure
Transcript identifiers
Ensembl transcripts: 22 — 15 protein_coding, 4 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000370784, ENST00000370785, ENST00000414371, ENST00000460216, ENST00000463842, ENST00000470657, ENST00000475361, ENST00000482240, ENST00000494709, ENST00000623326, ENST00000642481, ENST00000643150, ENST00000644752, ENST00000645176, ENST00000645256, ENST00000645288, ENST00000645433, ENST00000646004, ENST00000647516, ENST00000898787, ENST00000926068, ENST00000926069
RefSeq mRNA: 23 — MANE Select: NM_001388447
NM_001170779, NM_001170780, NM_001170781, NM_001170782, NM_001170783, NM_001170784, NM_001365743, NM_001365744, NM_001365745, NM_001365746, NM_001365747, NM_001365748, NM_001388440, NM_001388441, NM_001388442, NM_001388443, NM_001388444, NM_001388445, NM_001388446, NM_001388447, NM_001388448, NM_001388449, NM_138819
CCDS: CCDS14644, CCDS55500, CCDS55501, CCDS76028, CCDS87777, CCDS94669, CCDS94671, CCDS94672, CCDS94673, CCDS94674
Canonical transcript exons
ENST00000645433 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003494237 | 134845347 | 134845401 |
| ENSE00003524754 | 134847383 | 134847475 |
| ENSE00003541411 | 134814771 | 134814849 |
| ENSE00003617763 | 134847883 | 134847971 |
| ENSE00003623687 | 134807540 | 134807708 |
| ENSE00003643283 | 134829226 | 134829282 |
| ENSE00003719702 | 134845205 | 134845248 |
| ENSE00003755928 | 134807237 | 134807341 |
| ENSE00003818566 | 134852800 | 134852896 |
| ENSE00003819991 | 134849167 | 134849228 |
| ENSE00003916798 | 134854091 | 134854832 |
Expression profiles
Bgee: expression breadth ubiquitous, 177 present calls, max score 88.46.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.1159 / max 106.7747, expressed in 1520 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 197613 | 1.8178 | 815 |
| 197611 | 1.4269 | 666 |
| 197612 | 1.2220 | 666 |
| 197610 | 0.6916 | 184 |
| 197614 | 0.6103 | 278 |
| 197609 | 0.2644 | 118 |
| 209819 | 0.0642 | 31 |
| 197615 | 0.0187 | 8 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.46 | gold quality |
| left ovary | UBERON:0002119 | 85.83 | gold quality |
| bone marrow cell | CL:0002092 | 84.83 | gold quality |
| adrenal tissue | UBERON:0018303 | 84.24 | gold quality |
| ovary | UBERON:0000992 | 83.78 | gold quality |
| right ovary | UBERON:0002118 | 82.41 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.80 | gold quality |
| monocyte | CL:0000576 | 80.40 | gold quality |
| leukocyte | CL:0000738 | 80.15 | gold quality |
| right testis | UBERON:0004534 | 78.67 | gold quality |
| left testis | UBERON:0004533 | 78.43 | gold quality |
| testis | UBERON:0000473 | 78.35 | gold quality |
| ventricular zone | UBERON:0003053 | 78.17 | gold quality |
| ganglionic eminence | UBERON:0004023 | 77.34 | gold quality |
| granulocyte | CL:0000094 | 77.23 | gold quality |
| stromal cell of endometrium | CL:0002255 | 76.12 | gold quality |
| sperm | CL:0000019 | 75.68 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 75.04 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 74.80 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 74.76 | gold quality |
| lower esophagus | UBERON:0013473 | 74.75 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 74.44 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 74.37 | gold quality |
| adrenal gland | UBERON:0002369 | 74.00 | gold quality |
| vermiform appendix | UBERON:0001154 | 73.95 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 73.91 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 73.90 | silver quality |
| right adrenal gland | UBERON:0001233 | 73.78 | gold quality |
| body of uterus | UBERON:0009853 | 73.63 | gold quality |
| spleen | UBERON:0002106 | 73.51 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.92 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
48 targeting PABIR3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-577 | 99.78 | 69.13 | 2479 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-12124 | 99.68 | 69.17 | 2700 |
| HSA-MIR-7157-5P | 99.66 | 69.33 | 1829 |
| HSA-MIR-4310 | 99.59 | 68.84 | 2527 |
| HSA-MIR-302B-5P | 99.50 | 69.49 | 1857 |
| HSA-MIR-302D-5P | 99.50 | 69.34 | 1863 |
| HSA-MIR-3915 | 99.45 | 68.49 | 1905 |
| HSA-MIR-4762-3P | 99.43 | 69.72 | 2363 |
| HSA-MIR-2115-3P | 99.31 | 69.68 | 2026 |
| HSA-MIR-4477B | 99.23 | 70.49 | 1733 |
| HSA-MIR-29A-5P | 99.08 | 68.59 | 1813 |
| HSA-MIR-4801 | 98.96 | 69.42 | 2096 |
| HSA-MIR-361-5P | 98.95 | 70.16 | 1340 |
| HSA-MIR-374A-3P | 98.87 | 67.82 | 1531 |
| HSA-MIR-589-5P | 98.72 | 66.96 | 927 |
| HSA-MIR-4731-3P | 98.56 | 68.60 | 1860 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | pabir2 | ENSDARG00000036500 |
| mus_musculus | Pabir3 | ENSMUSG00000036013 |
| rattus_norvegicus | Pabir3 | ENSRNOG00000028011 |
| drosophila_melanogaster | CG4497 | FBGN0031895 |
| caenorhabditis_elegans | WBGENE00018518 |
Paralogs (2): PABIR2 (ENSG00000156504), PABIR1 (ENSG00000187866)
Protein
Protein identifiers
PABIR family member 1 — Q6P4D5 (reviewed: Q6P4D5)
All UniProt accessions (12): Q6P4D5, A0A087WU98, A0A2R8Y466, A0A2R8Y4Q6, A0A2R8Y5U9, A0A2R8Y6Q5, A0A2R8Y7I3, A0A2R8Y7S4, A0A2R8YFJ9, A0A2R8YFQ2, A0A2R8YGQ0, B3KQY3
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the FAM122 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6P4D5-1 | 1 | yes |
| Q6P4D5-2 | 2 | |
| Q6P4D5-3 | 3 |
RefSeq proteins (23): NP_001164250, NP_001164251, NP_001164252, NP_001164253, NP_001164254, NP_001164255, NP_001352672, NP_001352673, NP_001352674, NP_001352675, NP_001352676, NP_001352677, NP_001375369, NP_001375370, NP_001375371, NP_001375372, NP_001375373, NP_001375374, NP_001375375, NP_001375376, NP_001375377, NP_001375378, NP_620174 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026716 | PBIR1/2/3 | Family |
UniProt features (5 total): splice variant 4, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6P4D5-F1 | 63.45 | 0.15 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 117 (showing top):
GOBP_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, TGACCTY_ERR1_Q2, GOBP_REGULATION_OF_CATABOLIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_CATABOLIC_PROCESS, OCT1_07, GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_PROTEOLYSIS, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, GOBP_REGULATION_OF_PROTEOLYSIS, GOBP_PROTEIN_CATABOLIC_PROCESS, TGGAAA_NFAT_Q4_01, GOBP_PROTEOLYSIS, GOBP_POSITIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS
GO Biological Process (0):
GO Molecular Function (2): protein serine/threonine phosphatase inhibitor activity (GO:0004865), protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein serine/threonine phosphatase activity | 1 |
| protein phosphatase inhibitor activity | 1 |
| binding | 1 |
Protein interactions and networks
STRING
346 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PABIR3 | SAGE1 | Q9NXZ1 | 517 |
| PABIR3 | ADGRG2 | Q8IZP9 | 507 |
| PABIR3 | CDK16 | Q00536 | 491 |
| PABIR3 | SEPTIN6 | Q14141 | 478 |
| PABIR3 | OR52M1 | Q8NGK5 | 476 |
| PABIR3 | DIAPH2 | O60879 | 465 |
| PABIR3 | STS | P08842 | 460 |
| PABIR3 | IL1RAPL1 | Q9NZN1 | 458 |
| PABIR3 | SOWAHA | Q2M3V2 | 447 |
| PABIR3 | RIBC1 | Q8N443 | 446 |
| PABIR3 | SFT2D1 | Q8WV19 | 434 |
| PABIR3 | PBDC1 | Q9BVG4 | 433 |
| PABIR3 | RNF157 | Q96PX1 | 424 |
| PABIR3 | KIAA0513 | O60268 | 419 |
| PABIR3 | TXNDC16 | Q9P2K2 | 412 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CALR | PABIR3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| PABIR3 | JCHAIN | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (9): FAM122C (Two-hybrid), FAM122C (Affinity Capture-RNA), FAM122C (Affinity Capture-RNA), IGHA1 (Affinity Capture-MS), DMBT1 (Affinity Capture-MS), IGJ (Affinity Capture-MS), PIGR (Affinity Capture-MS), MUC5B (Affinity Capture-MS), FAM122C (Affinity Capture-RNA)
ESM2 similar proteins: A0A182BSS5, A0A1P8B590, F4HXU3, F4IG60, F4J4Y5, F4JU69, O81791, O84275, P03124, P0C6G1, P0C6G2, P0DKG3, P0DO60, P43580, P48731, P50084, Q06924, Q0JXE7, Q3EAI1, Q4PSJ7, Q5PP38, Q5U1Z7, Q6AWW4, Q6IM80, Q6J1A5, Q6P4D5, Q6REU5, Q6ZUJ4, Q7Y219, Q84V03, Q86SG4, Q8H045, Q8K3A6, Q8LGS1, Q8W4H1, Q941I2, Q94CK6, Q9C9F4, Q9C9X6, Q9D9H3
Diamond homologs: Q5ZLN7, Q6AYT4, Q6NZE7, Q6P4D5, Q7Z309, Q96E09, Q9DB52
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
71 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 16 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1699 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:134814769:A:AG | acceptor_gain | 1.0000 |
| X:134814770:G:GG | acceptor_gain | 1.0000 |
| X:134814770:GTTTT:G | acceptor_gain | 1.0000 |
| X:134845199:TTACA:T | acceptor_loss | 1.0000 |
| X:134845200:TACAG:T | acceptor_loss | 1.0000 |
| X:134845202:CA:C | acceptor_loss | 1.0000 |
| X:134845203:A:AC | acceptor_loss | 1.0000 |
| X:134845244:GAATG:G | donor_gain | 1.0000 |
| X:134845247:TG:T | donor_gain | 1.0000 |
| X:134845247:TGG:T | donor_loss | 1.0000 |
| X:134845248:GG:G | donor_gain | 1.0000 |
| X:134845249:G:GG | donor_gain | 1.0000 |
| X:134845249:GTGA:G | donor_loss | 1.0000 |
| X:134845250:T:A | donor_loss | 1.0000 |
| X:134852894:GTA:G | donor_gain | 1.0000 |
| X:134854089:A:AG | acceptor_gain | 1.0000 |
| X:134854090:G:GG | acceptor_gain | 1.0000 |
| X:134807707:GG:G | donor_gain | 0.9900 |
| X:134807708:GG:G | donor_gain | 0.9900 |
| X:134807708:GGTGA:G | donor_loss | 0.9900 |
| X:134807709:G:GG | donor_gain | 0.9900 |
| X:134807709:GT:G | donor_loss | 0.9900 |
| X:134807710:TGA:T | donor_loss | 0.9900 |
| X:134807711:GAG:G | donor_loss | 0.9900 |
| X:134814770:GT:G | acceptor_gain | 0.9900 |
| X:134814770:GTT:G | acceptor_gain | 0.9900 |
| X:134814770:GTTT:G | acceptor_gain | 0.9900 |
| X:134814845:CTCTG:C | donor_loss | 0.9900 |
| X:134814846:TCTG:T | donor_loss | 0.9900 |
| X:134814847:CTGG:C | donor_loss | 0.9900 |
AlphaMissense
1769 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:134829279:A:C | K81N | 0.805 |
| X:134829279:A:T | K81N | 0.805 |
| X:134845383:G:C | W109C | 0.744 |
| X:134845383:G:T | W109C | 0.744 |
| X:134807683:A:C | S29R | 0.722 |
| X:134807685:T:A | S29R | 0.722 |
| X:134807685:T:G | S29R | 0.722 |
| X:134814829:T:C | F57L | 0.690 |
| X:134814831:T:A | F57L | 0.690 |
| X:134814831:T:G | F57L | 0.690 |
| X:134852833:T:C | F127L | 0.687 |
| X:134852835:T:A | F127L | 0.687 |
| X:134852835:T:G | F127L | 0.687 |
| X:134814772:T:C | F38L | 0.631 |
| X:134814774:T:A | F38L | 0.631 |
| X:134814774:T:G | F38L | 0.631 |
| X:134829275:T:C | I80T | 0.628 |
| X:134829278:A:T | K81I | 0.602 |
| X:134829244:T:C | F70L | 0.597 |
| X:134829246:T:A | F70L | 0.597 |
| X:134829246:T:G | F70L | 0.597 |
| X:134852857:T:C | F135L | 0.592 |
| X:134852859:T:A | F135L | 0.592 |
| X:134852859:T:G | F135L | 0.592 |
| X:134854096:T:C | F150L | 0.590 |
| X:134854098:C:A | F150L | 0.590 |
| X:134854098:C:G | F150L | 0.590 |
| X:134845381:T:A | W109R | 0.586 |
| X:134845381:T:C | W109R | 0.586 |
dbSNP variants (sampled 300 via entrez): RS1000029834 (X:134802095 T>C), RS1000180848 (X:134812673 G>A), RS1000255991 (X:134819817 G>A), RS1000290999 (X:134852251 G>C), RS1000339196 (X:134822609 C>T), RS1000471524 (X:134822035 A>G), RS1000557275 (X:134844499 A>C), RS1000586396 (X:134822862 G>A), RS1000694595 (X:134844144 C>G,T), RS1000720717 (X:134812085 T>A), RS1000841775 (X:134795986 G>A), RS1000898393 (X:134832607 G>T), RS1000902779 (X:134854710 G>A,C), RS1000916673 (X:134865221 G>A,T), RS1000928044 (X:134796848 G>A,C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| terbufos | decreases methylation | 1 |
| sodium arsenite | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| nickel sulfate | increases expression | 1 |
| pentanal | decreases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| abrine | increases expression | 1 |
| NSC 689534 | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Fonofos | decreases methylation | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Parathion | decreases methylation | 1 |
| Phthalic Acids | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.